172 related articles for article (PubMed ID: 11094034)
21. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging.
Wyttenbach R; Corti R; Alerci M; Cozzi L; Di Valentino M; Segatto JM; Badimon JJ; Fuster V; Gallino A
Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):416-23. PubMed ID: 17689112
[TBL] [Abstract][Full Text] [Related]
22. External beam radiation to prevent restenosis after superficial femoral artery balloon angioplasty.
Therasse E; Donath D; Lespérance J; Tardif JC; Guertin MC; Oliva VL; Soulez G
Circulation; 2005 Jun; 111(24):3310-5. PubMed ID: 15956130
[TBL] [Abstract][Full Text] [Related]
23. Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study.
Hagenaars T; A Po IF; van Sambeek MR; Coen VL; Van Tongeren RB; Gescher FM; Wittens CH; Boelhouwer RU; Pattynama PM; Gussenhoven EJ
J Vasc Surg; 2002 Aug; 36(2):318-24. PubMed ID: 12170197
[TBL] [Abstract][Full Text] [Related]
24. Advances in vascular brachytherapy over the last 10 years: focus on femoropopliteal applications.
Schillinger M; Minar E
J Endovasc Ther; 2004 Dec; 11 Suppl 2():II180-91. PubMed ID: 15760248
[TBL] [Abstract][Full Text] [Related]
25. [PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)].
Grenacher L; Saam T; Geier A; Müller-Hülsbeck S; Cejna M; Kauffmann GW; Richter GM
Rofo; 2004 Sep; 176(9):1302-10. PubMed ID: 15346266
[TBL] [Abstract][Full Text] [Related]
26. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial.
Amighi J; Schillinger M; Dick P; Schlager O; Sabeti S; Mlekusch W; Haumer M; Mathies R; Heinzle G; Schuster A; Loewe C; Koppensteiner R; Lammer J; Minar E; Cejna M
Radiology; 2008 Apr; 247(1):267-72. PubMed ID: 18270378
[TBL] [Abstract][Full Text] [Related]
27. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
[TBL] [Abstract][Full Text] [Related]
28. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial.
Nicholson T
Cardiovasc Intervent Radiol; 1998; 21(6):470-4. PubMed ID: 9853164
[TBL] [Abstract][Full Text] [Related]
30. Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females?
Maca T; Ahmadi R; Derfler K; Hörl WH; Koppensteiner R; Minar E; Schneider B; Stümpflen A; Ehringer H
Atherosclerosis; 1996 Nov; 127(1):27-34. PubMed ID: 9006801
[TBL] [Abstract][Full Text] [Related]
31. Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients.
Ishii H; Kumada Y; Toriyama T; Aoyama T; Takahashi H; Tanaka M; Kamoi D; Kawamura Y; Yamada S; Hayashi M; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Clin Ther; 2010 Jan; 32(1):24-33. PubMed ID: 20171408
[TBL] [Abstract][Full Text] [Related]
32. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial.
Brodmann M; Rief P; Froehlich H; Dorr A; Gary T; Eller P; Hafner F; Deutschmann H; Seinost G; Pilger E
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):69-74. PubMed ID: 23007223
[TBL] [Abstract][Full Text] [Related]
33. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
[TBL] [Abstract][Full Text] [Related]
35. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging.
Wyttenbach R; Gallino A; Alerci M; Mahler F; Cozzi L; Di Valentino M; Badimon JJ; Fuster V; Corti R
Circulation; 2004 Aug; 110(9):1156-61. PubMed ID: 15326071
[TBL] [Abstract][Full Text] [Related]
36. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography.
Bui TD; Gordon IL; Nguyen T; Fujitani RM; Wilson SE; Conroy RC
Ann Vasc Surg; 2006 Mar; 20(2):200-8. PubMed ID: 16555031
[TBL] [Abstract][Full Text] [Related]
37. 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience.
Schopohl B; Leirmann D; Pohlit LJ; Heyd R; Strassmann G; Bauersachs R; Schulte-Huermann D; Rahl CG; Manegold KH; Kollath J; Bottcher HD
Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):835-40. PubMed ID: 8960510
[TBL] [Abstract][Full Text] [Related]
38. Endovascular interventions for TASC II D femoropopliteal lesions.
Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
[TBL] [Abstract][Full Text] [Related]
39. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
[TBL] [Abstract][Full Text] [Related]
40. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
